American Century Companies’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $97.9M | Sell |
1,614,388
-478,461
| -23% | -$27.9M | 0.05% | 439 |
|
|
2025
Q4 | $113M | Sell |
2,092,849
-172,773
| -8% | -$8.31M | 0.06% | 367 |
|
|
2025
Q3 | $102M | Sell |
2,265,622
-88,819
| -4% | -$4.15M | 0.05% | 398 |
|
|
2025
Q2 | $109M | Buy |
2,354,441
+97,089
| +4% | +$4.77M | 0.06% | 340 |
|
|
2025
Q1 | $138M | Sell |
2,257,352
-458,861
| -17% | -$26.7M | 0.08% | 232 |
|
|
2024
Q4 | $154M | Sell |
2,716,213
-53,605
| -2% | -$3M | 0.09% | 215 |
|
|
2024
Q3 | $143M | Buy |
2,769,818
+176,390
| +7% | +$8.27M | 0.08% | 232 |
|
|
2024
Q2 | $108M | Sell |
2,593,428
-232,327
| -8% | -$10.4M | 0.07% | 295 |
|
|
2024
Q1 | $153M | Sell |
2,825,755
-1,118,653
| -28% | -$57M | 0.1% | 220 |
|
|
2023
Q4 | $202M | Sell |
3,944,408
-484,641
| -11% | -$25.4M | 0.14% | 149 |
|
|
2023
Q3 | $257M | Sell |
4,429,049
-687,976
| -13% | -$42.2M | 0.2% | 102 |
|
|
2023
Q2 | $327M | Sell |
5,117,025
-81,694
| -2% | -$5.48M | 0.25% | 86 |
|
|
2023
Q1 | $360M | Sell |
5,198,719
-28,680
| -0.5% | -$2.02M | 0.28% | 73 |
|
|
2022
Q4 | $376M | Sell |
5,227,399
-322,534
| -6% | -$24.3M | 0.31% | 66 |
|
|
2022
Q3 | $395M | Buy |
5,549,933
+911,253
| +20% | +$66.1M | 0.35% | 53 |
|
|
2022
Q2 | $357M | Sell |
4,638,680
-568,446
| -11% | -$43.3M | 0.29% | 77 |
|
|
2022
Q1 | $380M | Buy |
5,207,126
+227,605
| +5% | +$15.3M | 0.26% | 94 |
|
|
2021
Q4 | $310M | Sell |
4,979,521
-186,339
| -4% | -$10.9M | 0.2% | 126 |
|
|
2021
Q3 | $306M | Sell |
5,165,860
-3,090
| -0.1% | -$203K | 0.21% | 122 |
|
|
2021
Q2 | $345M | Sell |
5,168,950
-215,073
| -4% | -$14M | 0.24% | 110 |
|
|
2021
Q1 | $340M | Sell |
5,384,023
-28,577
| -0.5% | -$1.78M | 0.25% | 103 |
|
|
2020
Q4 | $336M | Buy |
5,412,600
+204,861
| +4% | +$12.6M | 0.26% | 89 |
|
|
2020
Q3 | $314M | Sell |
5,207,739
-265,394
| -5% | -$16M | 0.28% | 90 |
|
|
2020
Q2 | $322M | Buy |
5,473,133
+153,882
| +3% | +$9.2M | 0.31% | 84 |
|
|
2020
Q1 | $296M | Buy |
5,319,251
+1,456,710
| +38% | +$89M | 0.35% | 71 |
|
|
2019
Q4 | $248M | Buy |
3,862,541
+2,198,969
| +132% | +$126M | 0.24% | 126 |
|
|
2019
Q3 | $84.4M | Sell |
1,663,572
-447,302
| -21% | -$21M | 0.08% | 263 |
|
|
2019
Q2 | $95.7M | Sell |
2,110,874
-207,756
| -9% | -$9.68M | 0.1% | 254 |
|
|
2019
Q1 | $111M | Sell |
2,318,630
-2,071,828
| -47% | -$103M | 0.11% | 240 |
|
|
2018
Q4 | $228M | Buy |
4,390,458
+1,125,410
| +34% | +$60.5M | 0.26% | 105 |
|
|
2018
Q3 | $203M | Buy |
3,265,048
+291,420
| +10% | +$17.3M | 0.2% | 152 |
|
|
2018
Q2 | $165M | Buy |
2,973,628
+662,337
| +29% | +$35.8M | 0.17% | 175 |
|
|
2018
Q1 | $146M | Buy |
2,311,291
+77,080
| +3% | +$4.96M | 0.15% | 203 |
|
|
2017
Q4 | $137M | Sell |
2,234,211
-69,912
| -3% | -$4.37M | 0.14% | 213 |
|
|
2017
Q3 | $147M | Sell |
2,304,123
-1,309,714
| -36% | -$76.5M | 0.15% | 199 |
|
|
2017
Q2 | $201M | Buy |
3,613,837
+21,135
| +0.6% | +$1.15M | 0.21% | 154 |
|
|
2017
Q1 | $195M | Sell |
3,592,702
-1,123,400
| -24% | -$61.6M | 0.2% | 149 |
|
|
2016
Q4 | $276M | Sell |
4,716,102
-250,084
| -5% | -$13.7M | 0.3% | 100 |
|
|
2016
Q3 | $268M | Sell |
4,966,186
-2,173,375
| -30% | -$140M | 0.29% | 98 |
|
|
2016
Q2 | $525M | Sell |
7,139,561
-406,535
| -5% | -$28.7M | 0.6% | 27 |
|
|
2016
Q1 | $482M | Buy |
7,546,096
+17,187
| +0.2% | +$1.08M | 0.56% | 30 |
|
|
2015
Q4 | $518M | Buy |
7,528,909
+309,574
| +4% | +$20.5M | 0.61% | 20 |
|
|
2015
Q3 | $427M | Buy |
7,219,335
+379,270
| +6% | +$24.1M | 0.52% | 35 |
|
|
2015
Q2 | $455M | Buy |
6,840,065
+2,243,027
| +49% | +$148M | 0.51% | 36 |
|
|
2015
Q1 | $297M | Sell |
4,597,038
-17,409
| -0.4% | -$1.09M | 0.33% | 82 |
|
|
2014
Q4 | $272M | Sell |
4,614,447
-1,923,839
| -29% | -$108M | 0.31% | 86 |
|
|
2014
Q3 | $335M | Sell |
6,538,286
-571,650
| -8% | -$28.6M | 0.39% | 59 |
|
|
2014
Q2 | $345M | Buy |
7,109,936
+892,068
| +14% | +$44M | 0.39% | 58 |
|
|
2014
Q1 | $323M | Sell |
6,217,868
-426,790
| -6% | -$22.7M | 0.38% | 49 |
|
|
2013
Q4 | $353M | Sell |
6,644,658
-1,042,034
| -14% | -$53.1M | 0.42% | 52 |
|
|
2013
Q3 | $356M | Buy |
7,686,692
+196,722
| +3% | +$8.64M | 0.45% | 49 |
|
|
2013
Q2 | $335M | Buy |
+7,489,970
| New | +$325M | 0.44% | 53 |
|
Other funds holding BMY
VCM
VPM
American Century Companies's BMY Position: Q1 2026 in Review
American Century Companies reduced its Bristol-Myers Squibb (BMY) stake by 23% in Q1 2026, selling an estimated $27.9M and leaving 1,614,388 shares worth $97.9M. The position accounts for 0.05% of the portfolio, ranked #439.
American Century Companies first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $525M in Q2 2016. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- American Century Companies held 1,614,388 shares of Bristol-Myers Squibb worth $97.9M as of Q1 2026.
- American Century Companies sold 478,461 Bristol-Myers Squibb shares in Q1 2026, an estimated $27.9M.
- Bristol-Myers Squibb made up 0.05% of American Century Companies's portfolio in Q1 2026, its #439 holding.
- American Century Companies first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
- American Century Companies's Bristol-Myers Squibb position peaked at $525M in Q2 2016.
- 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on American Century Companies's 13F filing for Q1 2026, filed 15 May 2026.